Location History:
- Paris, FR (1996 - 1998)
- Orly, FR (1998 - 2011)
Company Filing History:
12 out of 247 
5 out of 377 
2 out of 207 Years Active: 1996-2011
Title: Innovations and Contributions of Dominique Damour in the Pharmaceutical Industry
Introduction
Dominique Damour, an innovative inventor based in Orly, France, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 19 patents, Damour has focused on developing novel compounds that exhibit valuable therapeutic properties, particularly in oncology.
Latest Patents
Among his most recent innovations are two noteworthy patents. The first is titled "Azaindoles for Inhibiting Aurora2 and Other Kinases." This invention centers on physiologically active compounds of general formula (I), which includes novel compounds and compositions that demonstrate the ability to inhibit kinases. The implications of these compounds extend to their prodrugs and pharmaceutically acceptable salts and solvates, positioning them as potential breakthroughs in targeted therapy.
The second patent involves "Substituted Indazoles, Compositions Containing Them, Method of Production and Use." This invention is particularly significant as it details novel specific substituted indazoles that exhibit kinase-inhibiting activity. These compounds are designed to offer therapeutic effects, with a particular focus on applications in oncology, showcasing Damour's dedication to addressing critical medical needs.
Career Highlights
Throughout his career, Dominique Damour has collaborated with prominent pharmaceutical companies such as Rhône-Poulenc Rorer S.A. and Aventis Pharma S.A. His work in these organizations has enabled him to refine his research and contribute to the development of innovative therapies that target various diseases.
Collaborations
In his research journey, Damour has worked alongside notable colleagues like Serge Mignani and Jean-Claude Aloup. Their collaboration has fostered an environment of creativity and innovation, leading to the advancement of impactful pharmaceutical inventions that hold promise for future medical applications.
Conclusion
Dominique Damour stands out as a prolific inventor in the pharmaceutical sector. His extensive patent portfolio and dedicated work in developing kinase inhibitors reflect a commitment to enhancing therapeutic options for patients. As the pharmaceutical landscape continues to evolve, Damour's innovations are likely to play a crucial role in shaping future treatment strategies.